Trials / Active Not Recruiting
Active Not RecruitingNCT06029517
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
A Novel Sugar-Sweetened Beverage Reduction Intervention for Native American Men
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletics communities. Sugary drinks are drinks like pop, soda, and juice. Increased sugar consumption may lead to an increased risk of chronic diseases, including obesity, diabetes, some types of obesity-related cancers, coronary heart disease, hypertension, and dental decay. A culturally sensitive program may help reduce sugar-sweetened beverage consumption in Native American men
Detailed description
PRIMARY OBJECTIVE: I. Conduct and analyze qualitative data from focus groups and key informant interviews with Native American community members including Native American leaders and community members to develop Sugar Sweetened Beverage (SSB) intervention for Native American men (SIPsmartER Lacrosse). OUTLINE: AIM 1: Participants complete interviews over 60 minutes and attend focus groups over 90 minutes in support of intervention adaptation and refinement. AIM 2: Participants receive the Indigenous SIPin intervention over 6 months, which includes in-person and/or virtual educational sessions weekly over 30 minutes for 12 weeks and text message communications twice a week (BIW) for 12 weeks and then monthly thereafter up to month 6.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Education Intervention | Receive Indigneous SIPin intervention |
| OTHER | Interview | Complete interviews |
| PROCEDURE | Discussion | Attend focus groups |
Timeline
- Start date
- 2022-07-20
- Primary completion
- 2025-09-15
- Completion
- 2026-09-15
- First posted
- 2023-09-08
- Last updated
- 2025-12-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06029517. Inclusion in this directory is not an endorsement.